New Orthobunyavirus isolated from infected cattle and small livestock, potential implications for human health
In early November 2011 a new orthobunyavirus, provisionally named the Schmallenberg virus, was detected from infected cattle in Germany and the Netherlands. In addition, lambs infected with the same virus in utero resulting in congenital malformations have recently been reported from the Netherlands.
Based on current evidence, it is not possible to confirm or exclude a causal relationship between the detection of the new orthobunyavirus and clinical symptoms such a fever, diarrhoea, anorexia and decrease in milk yield being observed in cattle and small livestock. Epidemiological, immunological and microbiological investigations are ongoing in Germany and the Netherlands. According to Health Authorities in Germany and the Netherlands, further cases in cattle and small livestock are likely to be expected.
Previously, genetically similar orthobunyaviruses have not caused disease to humans. Therefore, it is unlikely that this virus would cause disease in humans, but it cannot be excluded at this stage. Close collaboration between animal and human health services is necessary to ensure rapid detection of any change of the epidemiology in animals and humans. In particular, the health of farmers and veterinarians in close contact with potentially infected animals should be carefully monitored.
Read the Risk assessment 'New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health', 22 December 2011
ECDC survey shows gaps in diphtheria diagnostic capacity across Europe
This ECDC gap analysis demonstrates that there are potentially significant gaps in diphtheria diagnostic capacity within the EU/EEA in terms of surveillance, specialised laboratory diagnostics, expertise and availability of diphtheria antitoxin (DAT). The results highlight the importance of sound surveillance systems for diphtheria and laboratory personnel training, as well as the need to ensure access to immunisation and high vaccination coverage rates.Read more
Antimicrobial resistance and causes of non-prudent use of antibiotics in human medicine: results of the ARNA project
The final report of the EU-funded project “Antimicrobial Resistance and causes of Non-prudent use of Antibiotics” (ARNA) highlights that in Europe 7% of all antibiotics used in 2016 were taken without prescription; the two main sources being over-the-counter (OTC) sales and use of leftover antibiotics.Read more
Epidemiological update: Measles - monitoring European outbreaks, 14 July 2017
Romania has been experiencing a large outbreak of measles since February 2016. Cases continue to be reported despite ongoing response measures implemented at national level through reinforced vaccination activities. Between 1 January 2016 and 07 July 2017, Romania reported 7 647 measles cases, including 31 deaths.Read more